Wold Stephen M, Derkay Craig S, Darrow David H, Proud Virginia
Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA 23507, United States.
Int J Pediatr Otorhinolaryngol. 2010 Jan;74(1):27-31. doi: 10.1016/j.ijporl.2009.09.042. Epub 2009 Nov 20.
Mucopolysaacharidoses (MPS) represent a spectrum of disorders characterized by the genetic deficiency of specific lysosomal enzymes occurring in as many as 1 in 10,000 live births and resulting in the accumulation of glycosaminoglycans within cells throughout the body. Children have highly variable, multi-systemic involvement that nearly always involves manifestations of the head and neck including recurrent otitis, hearing loss, upper airway obstruction, and characteristic coarse facial features. This places the otolaryngologist in a prime position for early recognition and initiation of treatment. We sought to examine our own experience in dealing with this diverse and often quite devastating clinical entity.
Retrospective chart review of children with mucopolysaccharidoses seen in our tertiary care pediatric otolaryngology clinic accompanied by review of the literature.
Nine children were identified--five with Hurler syndrome, three with Hunter syndrome, and one with Maroteaux-Lamy syndrome. The median age of diagnosis/genetics referral was 15 months, while median age of presentation to an otolaryngologist was 12 months. Three patients were referred for genetics evaluation based upon initial evaluation/suspicion by an otolaryngologist. Two were diagnosed early because of an affected older sibling. All patients in the series had varying degrees of hearing loss, recurrent otitis, chronic effusions or abnormal facial features, and all patients required placement of at least one set of ventilation tubes.
Otolaryngologists have an opportunity to play an increasingly integral role in the multidisciplinary approach to the diagnosis and management of many children with mucopolysaccharidoses. Clinical suspicion, early recognition, and prompt diagnosis of these challenging disorders is crucial, as outcomes of treatment in many cases appear time-sensitive, with better results being achieved when intervention is initiated at a younger age or prior to progression of the disease.
黏多糖贮积症(MPS)是一系列疾病,其特征为特定溶酶体酶的基因缺陷,在每10000例活产婴儿中发病率约为1例,导致全身细胞内糖胺聚糖蓄积。儿童有高度可变的多系统受累,几乎总是涉及头颈部表现,包括反复中耳炎、听力丧失、上气道梗阻以及特征性的面部粗糙面容。这使耳鼻喉科医生处于早期识别和开始治疗的首要位置。我们试图审视我们自己在处理这一多样且往往极具破坏性的临床实体方面的经验。
对在我们三级护理儿科耳鼻喉科诊所就诊的黏多糖贮积症患儿进行回顾性病历审查,并查阅文献。
共确定9例患儿——5例患有Hurler综合征,3例患有Hunter综合征,1例患有Maroteaux-Lamy综合征。诊断/基因转诊的中位年龄为15个月,而到耳鼻喉科就诊的中位年龄为12个月。3例患者是基于耳鼻喉科医生的初始评估/怀疑而被转诊进行基因评估。2例因有患病的年长同胞而早期确诊。该系列所有患者均有不同程度的听力丧失、反复中耳炎、慢性积液或异常面部特征,且所有患者均至少需要放置一组通气管。
在多学科方法诊断和管理许多黏多糖贮积症患儿方面,耳鼻喉科医生有机会发挥越来越重要的作用。对这些具有挑战性的疾病进行临床怀疑、早期识别和及时诊断至关重要,因为在许多情况下治疗结果似乎对时间敏感,在较年幼时或疾病进展之前开始干预可取得更好的效果。